|
|
|
|
Vulvar ulcers: Patient characteristics, lesion morphology provide clues for easy diagnosis
Source: Dermatology Times Email|Print| Del.icio.us Digg Reddit Facebook |Save|License 12 Key Points First step is determining if lesion is A true ulcer Aphthae is possibility if the patient is an adolescent or teen little research directed...
|
|
|
[Case reports] Vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation
_ [Case reports] Vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation.
|
|
|
uVIN-related vulvar SCC increases risk for cervical (pre)malignancies
MedWire News: Women with a usual (u) vulvar intraepithelial neoplasia (VIN)-related vulvar squamous cell carcinoma (SCC) have an increased incidence of cervical malignancies than women with differentiated (d)VIN, show study...
|
|
|
Merck admits the vaccine Gardasil, can cause faints and seizures
Due to the high volume of reports of young girls fainting and have 'non epileptic' seizures after the Gardasil vaccine, Merck have conceded to include these side effects to their packaging and labelling as from 9th June 2009.'On June 9,...
|
|
|
Merck admits the vaccine Gardasil, can cause faints and seizures
Due to the high volume of reports of young girls fainting and have 'non epileptic' seizures after the Gardasil vaccine, Merck have conceded to include these side effects to their packaging and labelling as from 9th June 2009.'On June 9,...
|
|
|
Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical
_ Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical.
|
|
|
Professor wins award for pain research - Caroline Pukall (Psychology) is one of two recipients of Pfizer Canad
Caroline Pukall (Psychology) is one of two recipients of Pfizer Canadas Neuropathic Pain Research Awards Competition.Pukalls work focuses on vulvodynia: vulvar discomfort in the absence of relevant visible findings or a specific,...
|
|
|
Norway Chooses The Four-Type HPV Vaccine Gardasil(R) For The National Vaccination Programme
) human papillomavirus (HPV) vaccine, Gardasil, has been chosen by the Norwegian authorities for the national vaccination programme after the assessment of a variety of criteria, including efficacy in the prevention of cervical cancer,...
|
|
|
MSD's cervical cancer vaccine gets WHO pre-qualification
WHITEHOUSE STATION, New Jersey MSDs human papillomavirus quadrivalent (Types 6, 11, 16 and 18) vaccine has been awarded World Health Organization (WHO) pre-qualification.It is the first cervical cancer vaccine to receive WHO pre...
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
WHO Pre-qualification Will Help to Facilitate Expanded Global Access and Implementation of HPV Vaccination Programs May 26, 2009 12:00 PM Eastern Daylight Time WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--GARDASIL [Human Papillomavirus...
|
|
|
GARDASIL Is First Cervical Cancer Vaccine To Receive WHO Pre-Qualification
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.GARDASIL is the first cervical cancer vaccine...
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
- GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.GARDASIL is the first cervical cancer...
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.GARDASIL is the first cervical cancer vaccine...
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.GARDASIL is the first cervical cancer vaccine...
|
|
|
GARDASIL(R) is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
BusinessWire - GARDASIL(R) [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.GARDASIL is the first...
|
|
|
Gardasil is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
WHO Pre-qualification Will Help to Facilitate Expanded Global Access and Implementation of HPV Vaccination Programs WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--May 26, 2009 - GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18...
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.
|
|
|
GARDASIL(R) is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- GARDASIL(R) [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.GARDASIL is the first cervical cancer vaccine...
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
WHO Pre-qualification Will Help to Facilitate Expanded Global Access and Implementation of HPV Vaccination Programs WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine,...
|
|
|
GARDASIL is First Cervical Cancer Vaccine to Receive WHO Pre-qualification
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification.
|
|
|
Studies of Gardasil, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of Gardasil Presented at In
Data from an Extension of a Phase II Study for an Average of 8.5 Years Evaluating the ongoing efficacy of HPV 16 Component of GARDASIL Presented Investigational Study with GARDASIL: Data Presented on Reduction in Abnormal Pap Tests and...
|
|
|
Studies of GARDASIL, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at I
MALMOE, Sweden--(BUSINESS WIRE)--In a study of an extended follow up of 290 women nave to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against...
|
